Thomson Reuters Foundation

Inform - Connect - Empower

TAKE A LOOK-Pfizer's pursuit of AstraZeneca

Source: Reuters - Tue, 13 May 2014 12:27 GMT
Author: Reuters
hum-war hum-dis
Tweet Recommend Google + LinkedIn Email Print
Leave us a comment

May 13 (Reuters) - U.S. drugmaker Pfizer is considering its next move in a politically charged battle for control of Britain's AstraZeneca , after having a $106 billion approach rejected. Following is a summary of Reuters reports on the matter: TOP STORIES > UK lawmakers give Pfizer stick as it waves carrot at Astra > Pfizer's science vows to Britain: promise or placebo? > BREAKINGVIEWS-AstraZeneca is no one's property > UK labs play shrinking role in AstraZeneca drug portfolio > UK's Cameron says making good progress on Pfizer guarantees

> UK finance minister ready for "hard negotiation" with Pfizer > In AstraZeneca fight, valuing drugs as much art as science > AstraZeneca fights bid by predicting sales surge - eventually > EU likely to block any UK intervention in Astra bid -lawyers > Maryland, Delaware governors concerned about Pfizer-Astra deal

> Fear of Pfizer-AstraZeneca job cuts voiced by U.S. lawmakers

> In $100 bln fight, R&D site marks political frontline GRAPHICS > AstraZeneca share price vs employees: http://link.reuters.com/gaq29v > AstraZeneca share price performance and valuation: http://link.reuters.com/nyp29v > Top 20 pharmaceutical companies by sales: http://link.reuters.com/guk98v > World pharmaceutical companies valuation: http://link.reuters.com/gaz97s

(Compiled by Pravin Char)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of the Thomson Reuters Foundation. For more information see our Acceptable Use Policy.

comments powered by Disqus